Our study found that when obesity and other controls were added as covariates, the odds of having a CRP level >1 mg/dL in the sleep apnea group decreased substantially, to nonstatistical significance (OR=2.46 compared to OR=1.33). This evidence concerns the gene CRP and obesity due to melanocortin 4 receptor deficiency.